Eric how about this trastumuzumab-MCC-DM1 open label for met bc who progressed on herceptin therapy and there is More Information
Study ID Numbers: TDM4258g
Last Updated: September 24, 2007
Record first received: July 27, 2007
ClinicalTrials.gov Identifier: NCT00509769
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on October 25, 2007
__________________
Lily Diag April/06 5 months after give birth my son Max stage IV mets on liver (5 tumors) 38 year old, her2+++ and ER+PR+ from32 nodes 4 positives mastectomy right breast chemo before surgery herceptin/carboplatin/taxotere ,clear and surgery have radiation 20, `& then herceptin and tamoxifen NED until Aug/07 body only then 'n June 04-06-07 .1 lesion of 1.6 cm on cerebellum ...novalis ,open sugery 5m.m brain met again novalis, 4mm.In the liver. Waiting 2 months now 3 tumors enroll on T-MCC trial start first infusion Nov 5/07 at Dec 17 scan show one tumor despair the 2nd and 3th diminish Doc said great results until March/08 ct scan show progression 03-05-08 start tykerb & xeloda
|